{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:05:50Z","timestamp":1794279950565,"version":"4.9.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Prader-Willi syndrome (PWS) is a genetic neurodevelopmental disorder with a characteristic trajectory. Infants display hypotonia, poor social and feeding skills, and high risk of choking, which have been shown to improve after oxytocin (OT) treatment. Our aim is to demonstrate the efficacy of intranasal OT treatment administered in the postnatal critical period on infant feeding skills and document its long-term effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We enrolled 52 infants with PWS (median age 2.2\u2009months) in a European double-blind randomized placebo-controlled study. Infants were randomly assigned in a 1:1 ratio to either 4 IU\/day of OT or placebo for a 4-week evaluation of efficacy. A second randomization in each group was performed. Infants in the placebo group were randomized into 4\u2009weeks of OT followed by 4\u2009weeks of placebo or 8 consecutive weeks of OT. Those in the OT group were randomized into additional 4\u2009weeks of OT followed by 4\u2009weeks of placebo or 8 consecutive weeks of placebo. Infants were followed-up to 26\u2009weeks from baseline. Feeding skills were evaluated using Neonatal Oral-Motor Scale (NOMAS) as primary endpoint and videofluoroscopy of swallowing study (VFSS) as key secondary endpoint. Subsequently, 40 infants included in France (OT-exposed cohort) participated in a new study to document long term safety of OT treatment and to compare them with an unexposed cohort (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200924) at about 3\u2009years of age. Prevalence and severity of comorbidities of the disorder were compared between the two cohorts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      OT was well tolerated. At 4\u2009weeks, NOMAS normalization rates were similar between OT and placebo, but OT yielded a higher VFSS responder rate (53.3% vs 16.7%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.05) and a greater reduction in VFSS total score (LS mean difference \u22121.55; 95% CI \u22122.9 to \u22120.2;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.03). At 3\u2009years, the OT-exposed cohort demonstrated consistently better motor, adaptive and behavioral outcomes than unexposed controls.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The primary endpoint did not show significant difference between OT and placebo groups. However, using VFSS we showed for the first time a positive effect of 4\u2009weeks intranasal OT treatment on swallowing. We also document long-term effect on disease trajectory, with less severe comorbidities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04214-8","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T08:47:24Z","timestamp":1770194844000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Oxytocin in infants with Prader-Willi syndrome to improve dysphagia and disease trajectory"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0363-7862","authenticated-orcid":false,"given":"Maithe","family":"Tauber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwenaelle","family":"Diene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Fichaux-Bourin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva","family":"Gueorguieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Nicolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Reynaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Bernoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Beauloye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin Malek","family":"Abrahimians","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cordula","family":"Kiewert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Payoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Cabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Molinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Glattard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Viaux-Savelon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Guedeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Arnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Valette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"4214_CR1","first-page":"1260","volume":"6","author":"A Prader","year":"1956","unstructured":"Prader A, Labhart A, Willi H. Ein Syndrom von Adipositas, Kleinwuchs, Kryptorchismus und Oligophrenie nach myatonieartigem Zustand im Neugeborenenalter. Schweiz medizinische Wochenschr. 1956;6:1260\u201361.","journal-title":"Schweiz medizinische Wochenschr"},{"key":"4214_CR2","unstructured":"Driscoll DJ, Miller JL, Cassidy SB. Prader-Willi Syndrome. In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews\u24c7 [Internet]. Seattle (WA): University of Washington, Seattle; 1993."},{"issue":"4","key":"4214_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S2213-8587(21)00002-4","volume":"9","author":"M Tauber","year":"2021","unstructured":"Tauber M, Hoybye C. Endocrine disorders in Prader-Willi syndrome: a model to understand and treat hypothalamic dysfunction. Lancet Diabetes Endocrinol. 2021;9(4):235\u201346.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"4214_CR4","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1002\/ajmg.a.33951","volume":"155A","author":"JL Miller","year":"2011","unstructured":"Miller JL, Lynn CH, Driscoll DC, Goldstone AP, Gold JA, Kimonis V, et al. Nutritional phases in Prader-Willi syndrome. Am J Med Genet A. 2011;155A(5):1040\u201349.","journal-title":"Am J Med Genet A"},{"issue":"24","key":"4214_CR5","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.1093\/hmg\/ddq424","volume":"19","author":"F Schaller","year":"2010","unstructured":"Schaller F, Watrin F, Sturny R, Massacrier A, Szepetowski P, Muscatelli F. A single postnatal injection of oxytocin rescues the lethal feeding behaviour in mouse newborns deficient for the imprinted Magel2 gene. Hum Mol Genet. 2010;19(24):4895\u2013905.","journal-title":"Hum Mol Genet"},{"issue":"23","key":"4214_CR6","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1093\/hmg\/ddx342","volume":"26","author":"LC Burnett","year":"2017","unstructured":"Burnett LC, Hubner G, LeDuc CA, Morabito MV, Carli JFM, Leibel RL. Loss of the imprinted, non-coding Snord116 gene cluster in the interval deleted in the Prader Willi syndrome results in murine neuronal and endocrine pancreatic developmental phenotypes. Hum Mol Genet. 2017;26(23):4606\u201316.","journal-title":"Hum Mol Genet"},{"key":"4214_CR7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.nbd.2018.09.017","volume":"121","author":"T Ates","year":"2019","unstructured":"Ates T, Oncul M, Dilsiz P, Topcu IC, Civas CC, Alp MI, et al. Inactivation of Magel2 suppresses oxytocin neurons through synaptic excitation-inhibition imbalance. Neurobiol Dis. 2019;121:58\u201364.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"4214_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.biopsych.2014.11.010","volume":"78","author":"H Meziane","year":"2015","unstructured":"Meziane H, Schaller F, Bauer S, Villard C, Matarazzo V, Riet F, et al. An early postnatal oxytocin treatment prevents social and learning deficits in adult mice deficient for Magel2, a gene involved in Prader-Willi syndrome and autism. Biol Psychiatry. 2015;78(2):85\u201394.","journal-title":"Biol Psychiatry"},{"key":"4214_CR9","doi-asserted-by":"crossref","unstructured":"Tauber M, Boulanouar K, Diene G, Cabal-Berthoumieu S, Ehlinger V, Fichaux-Bourin P, et al. The use of oxytocin to improve feeding and social skills in infants with Prader-Willi syndrome. Pediatrics. 2017;139(2).","DOI":"10.1542\/peds.2016-2976"},{"issue":"4 Pt B","key":"4214_CR10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jphysparis.2017.08.001","volume":"110","author":"S Viaux-Savelon","year":"2016","unstructured":"Viaux-Savelon S, Rosenblum O, Guedeney A, Diene G, Cabal-Berthoumieu S, Fichaux-Bourin P, et al. Dyssynchrony and perinatal psychopathology impact of child disease on parents-child interactions, the paradigm of Prader Willi syndrom. J Physiol Paris. 2016;110(4 Pt B):427\u201333.","journal-title":"J Physiol Paris"},{"issue":"11","key":"4214_CR11","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1002\/ajmg.a.40480","volume":"176","author":"LJ Rice","year":"2018","unstructured":"Rice LJ, Woodcock K, Einfeld SL. The characteristics of temper outbursts in Prader-Willi syndrome. Am J Med Genet A. 2018;176(11):2292\u2013300.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"4214_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13023-025-03560-3","volume":"20","author":"M Valette","year":"2025","unstructured":"Valette M, Diene G, Glattard M, Cortadellas J, Molinas C, Faye S, et al. Early oxytocin treatment in infants with Prader-Willi syndrome is safe and is associated with better endocrine, metabolic and behavioral outcomes. Orphanet J Rare Dis. 2025;20(1):96.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"4214_CR13","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/ajmg.a.38015","volume":"173","author":"RD Gross","year":"2017","unstructured":"Gross RD, Gisser R, Cherpes G, Hartman K, Maheshwary R. Subclinical dysphagia in persons with Prader-Willi syndrome. Am J Med Genet A. 2017;173(2):384\u201394.","journal-title":"Am J Med Genet A"},{"issue":"50","key":"4214_CR14","doi-asserted-by":"publisher","first-page":"e 9256","DOI":"10.1097\/MD.0000000000009256","volume":"96","author":"P Salehi","year":"2017","unstructured":"Salehi P, Stafford HJ, Glass RP, Leavitt A, Beck AE, McAfee A, et al. Silent aspiration in infants with Prader-Willi syndrome identified by videofluoroscopic swallow study. Med (Baltim). 2017;96(50):e 9256.","journal-title":"Med (Baltim)"},{"key":"4214_CR15","doi-asserted-by":"crossref","unstructured":"Roy SM, Trejo A, McReynolds J, Fagerman A, Johnson YR, Neblett A, et al. High rates of dysphagia and silent aspiration in infants with Prader-Willi syndrome. Am J Med Genet A. 2025;e64121.","DOI":"10.1002\/ajmg.a.64121"},{"issue":"7","key":"4214_CR16","doi-asserted-by":"publisher","first-page":"e12728","DOI":"10.1111\/jne.12728","volume":"31","author":"M Tauber","year":"2019","unstructured":"Tauber M, Coupaye M, Diene G, Molinas C, Valette M, Beauloye V. Prader-Willi syndrome: a model for understanding the ghrelin system. J Neuroendocrinol. 2019;31(7):e12728.","journal-title":"J Neuroendocrinol"},{"key":"4214_CR17","doi-asserted-by":"crossref","unstructured":"Wang P, Chen X, Chen M, Gao L, Xiong B, Ji C, et al. Dysphagia pattern in early to moderate Parkinson\u2019s disease caused by abnormal pharyngeal kinematic function. Dysphagia. 2024.","DOI":"10.1007\/s00455-024-10672-8"},{"issue":"6","key":"4214_CR18","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.3390\/cimb45060313","volume":"45","author":"C Camerino","year":"2023","unstructured":"Camerino C. Oxytocin\u2019s regulation of thermogenesis May Be the link to Prader-Willi syndrome. Curr Issues Mol Biol. 2023;45(6):4923\u201335.","journal-title":"Curr Issues Mol Biol"},{"issue":"9","key":"4214_CR19","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1152\/physiolgenomics.00226.2010","volume":"43","author":"N De Jager","year":"2011","unstructured":"De Jager N, Hudson NJ, Reverter A, Wang YH, Nagaraj SH, Cafe LM, et al. Chronic exposure to anabolic steroids induces the muscle expression of oxytocin and a more than fiftyfold increase in circulating oxytocin in cattle. Physiol Genomics. 2011;43(9):467\u201378.","journal-title":"Physiol Genomics"},{"issue":"5","key":"4214_CR20","doi-asserted-by":"publisher","first-page":"e36787","DOI":"10.1371\/journal.pone.0036787","volume":"7","author":"S Arrowsmith","year":"2012","unstructured":"Arrowsmith S, Quenby S, Weeks A, Burdyga T, Wray S. Poor spontaneous and oxytocin-stimulated contractility in human myometrium from postdates pregnancies. PLoS One. 2012;7(5):e36787.","journal-title":"PLoS One"},{"issue":"3","key":"4214_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1177\/0963721421993822","volume":"30","author":"JM Iverson","year":"2021","unstructured":"Iverson JM. Developmental variability and developmental cascades: lessons from motor and language development in infancy. Curr Dir Psychol Sci. 2021;30(3):228\u201335.","journal-title":"Curr Dir Psychol Sci"},{"issue":"21","key":"4214_CR22","doi-asserted-by":"publisher","first-page":"e2415432","DOI":"10.1002\/advs.202415432","volume":"12","author":"ZH Wang","year":"2025","unstructured":"Wang ZH, Xu C, Ma YY, Xue WX, Wang HY, Fan LY, et al. Oxytocin improves autistic behaviors by positively shifting GABA reversal potential via NKCC1 in early-postnatal-Stage. Adv Sci (Weinh). 2025;12(21):e2415432.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"4214_CR23","doi-asserted-by":"publisher","first-page":"e15540","DOI":"10.1111\/ped.15540","volume":"65","author":"Y Oto","year":"2023","unstructured":"Oto Y, Murakami N, Imatani K, Inoue T, Itabashi H, Shiraishi M, et al. Perinatal and neonatal characteristics of Prader-Willi syndrome in Japan. Pediatr Int. 2023;65(1):e15540.","journal-title":"Pediatr Int"},{"issue":"6","key":"4214_CR24","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/BF00210291","volume":"96","author":"G Gillessen-Kaesbach","year":"1995","unstructured":"Gillessen-Kaesbach G, Robinson W, Lohmann D, Kaya-Westerloh S, Passarge E, Horsthemke B. Genotype-phenotype correlation in a series of 167 deletion and non-deletion patients with Prader-Willi syndrome. Hum Genet. 1995;96(6):638\u201343.","journal-title":"Hum Genet"},{"issue":"2","key":"4214_CR25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jpeds.2008.08.008","volume":"154","author":"U Eiholzer","year":"2009","unstructured":"Eiholzer U, Meinhardt U, Gallo C, Schlumpf M, Rousson V, l\u2019Allemand D. Association between foot growth and musculoskeletal loading in children with Prader-Willi syndrome before and during growth hormone treatment. J Pediatr. 2009;154(2):225\u201329.","journal-title":"J Pediatr"},{"issue":"4","key":"4214_CR26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1352\/1944-7558-120.4.315","volume":"120","author":"ST Lo","year":"2015","unstructured":"Lo ST, Festen DA, Tummers-de Lind van Wijngaarden RF, Collin PJ, Hokken-Koelega AC. Beneficial effects of long-term growth hormone treatment on adaptive functioning in infants with Prader-Willi syndrome. Am J Intellect Dev Disabil. 2015;120(4):315\u201327.","journal-title":"Am J Intellect Dev Disabil"},{"issue":"1","key":"4214_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00776-014-0651-y","volume":"20","author":"Y Nakamura","year":"2015","unstructured":"Nakamura Y, Murakami N, Iida T, Ozeki S, Asano S, Nohara Y, et al. The characteristics of scoliosis in Prader-Willi syndrome (PWS): analysis of 58 scoliosis patients with PWS. J Orthop Sci. 2015;20(1):17\u201322.","journal-title":"J Orthop Sci"},{"issue":"1","key":"4214_CR28","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/jcpp.12601","volume":"58","author":"EM Dykens","year":"2017","unstructured":"Dykens EM, Roof E, Hunt-Hawkins H. Cognitive and adaptive advantages of growth hormone treatment in children with Prader-Willi syndrome. J Child Psychol Psy. 2017;58(1):64\u201374.","journal-title":"J Child Psychol Psy"},{"issue":"7","key":"4214_CR29","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1136\/archdischild-2016-311298","volume":"102","author":"A Khayat","year":"2017","unstructured":"Khayat A, Narang I, Bin-Hasan S, Amin R, Al-Saleh S. Longitudinal evaluation of sleep disordered breathing in infants with Prader-Willi syndrome. Archiv Disease Child. 2017;102(7):634\u201338.","journal-title":"Archiv Disease Child"},{"issue":"12","key":"4214_CR30","doi-asserted-by":"publisher","first-page":"104064","DOI":"10.1016\/j.ejmg.2020.104064","volume":"63","author":"PH Roux-Levy","year":"2020","unstructured":"Roux-Levy PH, Bournez M, Masurel A, Jean N, Chancenotte S, Bordes M, et al. Associations between cognitive performance and the rehabilitation, medical care and social support provided to French children with Prader-Willi syndrome. Eur J Med Genet. 2020;63(12):104064.","journal-title":"Eur J Med Genet"},{"key":"4214_CR31","doi-asserted-by":"crossref","unstructured":"van Bosse HJP, Butler MG. Clinical observations and treatment approaches for scoliosis in Prader-Willi syndrome. Genes (Basel). 2020;11(3).","DOI":"10.3390\/genes11030260"},{"issue":"1","key":"4214_CR32","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12886-021-02057-4","volume":"21","author":"JE Bohonowych","year":"2021","unstructured":"Bohonowych JE, Vrana-Diaz CJ, Miller JL, McCandless SE, Strong TV. Incidence of strabismus, strabismus surgeries, and other vision conditions in Prader-Willi syndrome: data from the global Prader-Willi syndrome registry. BMC Ophthalmol. 2021;21(1):296.","journal-title":"BMC Ophthalmol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04214-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04214-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04214-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:04:26Z","timestamp":1781651066000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04214-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4214"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04214-8","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"19 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The clinical study OTBB3 and OTBB3-FUP studies were approved by the Comit\u00e9 de Protection des Personnes Sud-Ouest et Outremer I and by CPP-Ile-de-France VI respectively. Written informed consent was provided by the parents of the children.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication has been obtained from the parents of the children for the publication of their children photographs.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Maithe Tauber has a patent (PCT\/EP2011\/058590) licensed to OT4B in the framework of partnership with CHU Toulouse. Maithe Tauber reports receiving honorarium fees from OT4B for scientific advisory activities. The rest of the authors have indicated they have no conflicts of interest relevant to this article to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}